View Single Post
Old 07-21-2010, 07:22 PM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 20,053
Avastin – breast cancer drug, fails to pass the FDA advisory panel vote on efficacy

According to a Food and Drug Administration (FDA) advisory committee’s (The Oncology Drugs Advisory Committee, or ODAC) recommendation this Tuesday, the marketing approval of the popular breast cancer drug, Avastin or Bevacizumab should be withdrawn.

More...
News is offline   Reply With Quote